We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
USA - April 4 2013
In an unprecedented leak of confidential financial information relating to the identity and details of more than a reported 100,000 individuals and…
USA - March 8 2013
This is a follow-up to our post late last year on the Second Circuit decision in US v. Caronia, which overturned a defendant's off-label marketing…
USA - December 10 2012
Applying the First Amendment in a way that could significantly alter the prosecutorial and regulatory landscape in Food and Drug cases, the United States Court of Appeals for the Second Circuit has overturned the conviction of a pharmaceutical sales representative for conspiring to introduce a misbranded drug into interstate commerce, where his prosecution and conviction were based on conversations he had with physicians about off-label uses for an approved drug.
USA - November 26 2012
On November 14, 2012, the Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) issued “A Resource Guide to the U.S. Foreign Corrupt Practices Act,” a highly anticipated joint guidance aimed at assisting companies with FCPA compliance.
USA - March 23 2012
On March 14, BizJet International Sales and Support, Inc. (“BizJet”), signed a Deferred Prosecution Agreement (”DPA”) with the Department of Justice (DOJ), the terms of which will allow it to pay $11.8 million to the United States in order to avoid criminal prosecution under the Foreign Corrupt Practices Act (“FCPA”).
